Sample results
Hemolytic Disease of the Newborn (HDN) is a blood disorder where a mother's antibodies attack and destroy her baby's red blood cells during pregnancy or after birth. It is caused by blood type incompatibility between mother and baby, most commonly Rh incompatibility when an Rh-negative mother carries an Rh-positive baby, or ABO incompatibility when a type O mother carries a baby with type A, B, or AB blood. The Rh Typing test combined with Antibody Screen is the most important test for diagnosis and prevention of HDN.
Hemolytic Disease of the Newborn is caused by blood type incompatibility between mother and baby. The most common cause is Rh incompatibility, which occurs when an Rh-negative mother carries an Rh-positive baby inherited from the father. When the baby's Rh-positive blood cells enter the mother's bloodstream during pregnancy or delivery, her immune system recognizes them as foreign and produces antibodies against them. These antibodies can cross the placenta and attack the baby's red blood cells, causing them to break down. ABO incompatibility is another cause, occurring when a type O mother carries a baby with type A, B, or AB blood.
The Rh Typing test is the most important test for preventing Hemolytic Disease of the Newborn because it identifies whether a pregnant woman has Rh-negative blood, which is the primary risk factor for developing this condition. This simple blood test determines your Rh factor status early in pregnancy, allowing your doctor to monitor for incompatibility if your baby inherits Rh-positive blood from the father. The Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing is essential as a follow-up test because it detects whether your immune system has already started producing antibodies against your baby's blood cells and measures the severity of the antibody response. The ABO Grouping and Rho(D) Typing provides comprehensive information about both your ABO blood type and Rh factor, catching both types of incompatibility that can cause HDN.
You should get tested during your first prenatal visit in early pregnancy, ideally within the first trimester. All pregnant women need blood typing and antibody screening as part of routine prenatal care, regardless of whether this is their first pregnancy. If you are Rh-negative, you will need repeat antibody screening around 28 weeks of pregnancy to check if antibodies have developed. Women who have had previous pregnancies, miscarriages, abortions, or blood transfusions should be especially vigilant about early testing since previous exposure to incompatible blood increases the risk of antibody formation. Getting tested early allows your healthcare provider to administer preventive treatments like Rh immunoglobulin injections that can stop HDN from developing.
What this means
Your test shows you are Rh-negative, meaning you don't have the Rh antigen on your red blood cells. If you're pregnant or planning pregnancy and your partner is Rh-positive, you may need Rh immune globulin (RhoGAM) to prevent complications in future pregnancies.
Recommended actions
Discuss RhoGAM treatment timing with your obstetrician if pregnant
Inform all healthcare providers of your Rh-negative status
Ensure your partner gets tested to determine baby's potential Rh type
Keep a record of your Rh type for future pregnancies and medical procedures
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: